aggregation and degradation may follow with loss of biological activity
Effects of tesamorelin (TH9507), a growth hormone-releasing factor analog, in HIV-infected patients with excess abdominal fat: pooled analysis of two multicenter Phase 3 trials with safety extension data
As an aside, in a randomized, double-blind, placebo-controlled study, the addition of STS (80 mg/day, IV for 2 days before and 3 days after PCI) to the standard treatments could alleviate myocardial injury and the occurrence of short-term cardiovascular events in patients with non-ST elevation acute coronary receiving PCI [156]
0.22 m) immediately prior to use Aliquot and store reconstituted solutions at 20 C (or lower) to minimise degradation Avoid repeated freezethaw cycles Specifications Summary Precautions & Notes Experimental behaviour of IGF-1 LR3 is influenced by receptor expression, concentration, and exposure duration Modified IGF-1 analogues may exhibit signalling profiles distinct from native IGF-1 Buffer composition, pH, and ionic strength may affect peptide stability and assay performance Appropriate controls are recommended to distinguish specific from non-specific effects Intended strictly for laboratory research use
Stability & handling Lyophilized shelf life Up to ~24 months from manufacture at 20C (vendor-claimed